Using this strategy, the 5 PML patients were found to share only 2 identical TRB sequences at the time of PML onset, while 44 identical sequences were identified when only the four natalizumab-treated PML ones were considered. The gene discussed is PML; the disease is progressive multifocal leukoencephalopathy.